Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Editorial Volume 6 Issue 8

Editorial onDietary Fat

Melaku Tafese Awulachew*

Food Science and Nutrition Research, Ethiopian Institute of Agricultural Research, Ethiopia

*Corresponding Author: Melaku Tafese Awulachew, Food Science and Nutrition Research, Ethiopian Institute of Agricultural Research, Ethiopia.

Received: June 28, 2022; Published: July 01, 2022

Abstract

Cardiovascular disease is still the world's leading cause of death [1]. Dyslipidemia is one of the most important risk factors for cardiovascular disease. Dyslipidemia is caused by a disruption in lipoprotein metabolism, of which dietary fat absorption is a prominent component.

Keywords: Absorption Advance; Bile Acid; Apolipoprotein; Lipoprotein; Lipid; Gut; Chylomicron; Very Low-Density Lipoproteins; Lymph

References

  1. WHO (2020).
  2. Cifarelli V., et al. “Editorial: the role of the lymphatic system in lipid and energy metabolism, and immune homeostasis during obesity and diabetes”. Frontiers in Physiology 12 (2021): 652461.
  3. Levy E., et al. “From Congenital Disorders of Fat Malabsorption to Understanding Intra-Enterocyte Mechanisms behind Chylomicron Assembly and Secretion”. Frontiers in Physiology 12 (2021): 629222.
  4. Kusters D M., et al. “Dilemmas in treatment of women with familial hypercholesterolaemia during pregnancy”. Netherlands Journal of Medicine 68 (2010): 299-303.
  5. Fitzpatrick LR and Jenabzadeh P. “IBD and Bile Acid Absorption: Focus on Pre-clinical and Clinical Observations”. Frontiers in Physiology 11 (2020): 564.
  6. Vitek, L. “Bile acid malabsorption in inflammatory bowel disease”. Inflammatory Bowel Disease 21 (2015): 476-483.
  7. Lo CC and Coschigano KT. “ApoB48 as an Efficient Regulator of Intestinal Lipid Transport”. Frontiers in Physiology 11 (2020): 796.
  8. Lo C M., et al. “Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?” American Journal of Physiology-Gastrointestinal and Liver Physiology 294 (2008): G344-G352.
  9. Trevaskis NL., et al. “Intestinal Lymph Flow, and Lipid and Drug Transport Scale Allometrically From Pre-clinical Species to Humans”. Frontiers in Physiology 11 (2020): 458.
  10. McMillan DW., et al. “Effect of Paraplegia on the Time Course of Exogenous Fatty Acid Incorporation into the Plasma Triacylglycerol Pool in the Postprandial State”. Frontiers in Physiology 12 (2021): 626003.

Citation

Citation: Melaku Tafese Awulachew. “Editorial onDietary Fat". Acta Scientific Pharmaceutical Sciences 6.8 (2022): 01-02.

Copyright

Copyright: © 2022 Melaku Tafese Awulachew. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is October 10, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US